{
  "id": 9159403,
  "title": "STAT+: Did the Trump administration just cut Novo a huge financial win?",
  "url": "https://urgent.news/2026/09/22/stat-did-the-trump-administration-just-cut-novo-a-huge-financial-win",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T16:23:21.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/09/22/dc-diagnosis-did-trump-administration-cut-novo-huge-financial-win/"
  },
  "original_language": "en",
  "account": "STAT+ delves into whether the Trump administration may have just delivered a significant financial boon to Novo Nordisk. The outlet previously reported on the advantageous deals struck by both Eli Lilly and Novo Nordisk to lower the costs of obesity drugs for seniors under the Trump administration. According to the latest piece, Novo Nordisk may have received an additional advantage in these negotiations. Readers interested in the full story can continue their read on STAT+.",
  "summary": "The White House's GENEROUS plan was designed to make drugs more affordable for Medicaid users. There's one glaring potential exception.",
  "key_points": [
    "Trump administration may have cut Novo Nordisk a financial win",
    "Novo Nordisk benefited from deals lowering obesity drug costs for seniors",
    "Article suggests additional advantage in negotiations for Novo Nordisk"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}